Riskpilot← Back to searchSign inGet full accessMASOMEDICKA AB
ABActiveOrg 5592259302Siktgatan 2 5 TrGeneral medical practice activities · NACE 8621Est. 201916 employees
Revenue 2024
SEK 34,7M
+17% vs 2023
EBITDA margin
26.2%
-23% vs 2023
Equity ratio
65.6%
Financial strength
Net profit 2024
SEK 11M
+56% vs 2023
| Revenue | SEK 34,7M | +17% |
| EBITDA | SEK 9,1M | -23% |
| Net profit | SEK 11M | +56% |
| Total assets | SEK 17,2M | +8% |
| Equity | SEK 11,3M | +34% |
| Employees | 16 | — |
Legal name
MASOMEDICKA AB
Org number
5592259302
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 november 2019
Share capital
SEK 50 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Siktgatan 2 5 Tr
Email
info@vasterortsvc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 6 176 | 20 319 | 29 802 | 34 728 |
| Staff expenses | — | — | −8 206 | −10 851 | — |
| EBITDA | −7 | 345 | 7 143 | 11 839 | 9 089 |
| Depreciation & amort. | −0 | −0 | −36 | −36 | −44 |
| EBIT | −7 | 345 | 7 107 | 11 803 | 9 045 |
| Net financials | −6 | −27 | −27 | 0 | −13 |
| Profit before tax | −13 | 241 | 5 310 | 8 840 | 13 839 |
| Tax | −0 | −47 | −1 096 | −1 836 | −2 888 |
| Net profit | −13 | 194 | 4 214 | 7 003 | 10 951 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 039 | 3 811 | 8 251 | 15 971 | 17 218 |
| Equity | 37 | 230 | 4 444 | 8 448 | 11 299 |
| Long-term debt | 1 000 | 2 556 | 0 | — | 0 |
| Short-term debt | 3 | 948 | 1 960 | 2 713 | 5 916 |
| Total debt | 1 003 | 3 504 | 1 960 | 2 713 | 5 916 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20202024
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20202024
Return on equity
96.9%
This company
18.4%
Market median
+427% vs market
20202024
Net profit margin
31.5%
This company
8.1%
Market median
+289% vs market
20202024
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PA Audit | Audit | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MASOMEDICKA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pekka Anderman | Audit | 0 companies |
| Mitra Iranmahd | Chairman | 0 companies |
| Said Gacanin | Board of Directors | 0 companies |
| Mohamad Amin Sulayman | Board of Directors | 0 companies |